Internal Medicine The Japanese Society of Internal Medicine
[ CASE REPORT ]
Endoscopic Ultrasonography-guided Fine-needle Aspiration Revealed Metastasis-induced Acute Pancreatitis in a Patient with Adrenocortical Carcinoma
Toshitaka Mori1, Hiromu Kondo’, Itaru Naitoh2, Tetsuo Koyama’, Yuya Takenaka’,
Hirohiko Komai1, Sachiko Araki’, Mika Kitagawa2, Nobuhiro Nishigaki1, Yoshito Tanaka’, Keisuke Itoh1, Chihiro Hasegawa’, Takashi Kawai1 and Kazuki Hayashi2
Abstract:
A 26-year-old woman complained of upper abdominal pain. Computed tomography (CT) showed acute pancreatitis, a left adrenal tumor and solitary right pulmonary metastasis. She underwent left adrenalectomy; the adrenal tumor was diagnosed as adrenocortical carcinoma (ACC). When preparing to resect the pulmo- nary metastasis, she suffered a second acute pancreatic attack. Magnetic resonance cholangiopancreatography (MRCP) showed that the proximal main pancreatic duct (MPD) was dilated, and the distal MPD was dimin- ished; however, no pancreatic tumor was observed on CT or MRCP. Endoscopic ultrasonography revealed a solitary pancreatic mass, which was diagnosed as pancreatic metastasis from ACC by endoscopic ultrasonography-guided fine-needle aspiration.
Key words: metastasis-induced acute pancreatitis, adrenocortical carcinoma, endoscopic ultrasonography- guided fine-needle aspiration
(Intern Med 58: 2645-2649, 2019)
(DOI: 10.2169/internalmedicine.2450-18)
Introduction
Adrenocortical carcinoma (ACC) is a rare and highly ag- gressive malignancy with an annual incidence of 0.7-2.0 cases per million individuals. The initial manifestations of ACC are Cushing’s syndrome and/or virilization presenting as an abdominal mass or the feeling of abdominal fullness. Acute pancreatitis has never been reported as an initial manifestation of ACC.
There are various causes of acute pancreatitis, including alcohol, choledocholithiasis, hypertriglyceridemia, pancreatic divisum, sphincter of Oddi dysfunction, and pancreatic tu- mors. Metastasis-induced acute pancreatitis (MIAP) is very rare and initially manifests as cancer. In cases of MIAP, the original cancer is usually in the lung, especially small cell lung cancer (SCLC), although renal cell carcinoma has also
been reported.
We herein report the first case of a patient with ACC pre- senting as an initial manifestation of MIAP and reveal that endoscopic ultrasonography-guided fine-needle aspiration (EUS-FNA) can be used to diagnose metastasis from ACC.
Case Report
A 26-year-old woman visited our hospital with upper ab- dominal pain. Her medical history and family history were not remarkable. She worked as a bar hostess and so con- sumed alcohol habitually (>100 g ethanol per day) and smoked.
Computed tomography (CT) showed a left adrenal tumor (110×77 mm in diameter), and imaging revealed acute pan- creatitis (enlargement of the pancreatic parenchyma and stranding of the surrounding fat). Her serum amylase (1,084
Department of Gastroenterology, Nagoya City East Medical Center, Japan and 2Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan
Received: November 29, 2018; Accepted: March 19, 2019; Advance Publication by J-STAGE: June 7, 2019
Correspondence to Dr. Hiromu Kondo, hkondo@higashi-hosp.jp
a
b
₹
C
d
U/L; normal range: 37.0-125 U/L), white blood cell count (9,940/mm3; normal range: 3,500-8,000/mm3), and C- reactive protein (18.0 mg/dL; normal range: 0.0-0.3 mg/dL) values were elevated. We diagnosed her with acute pancrea- titis caused by alcohol and an incidental adrenal tumor. To diagnose the adrenal tumor, we conducted an endocrinologic examination. She had no typical symptoms of Cushing’s syndrome, such as moon face or central obesity, pheochro- mocytoma, or virilization. There was no 123I metaiodobenzyl- guanidine uptake in the left adrenal tumor, and urine metanephrine and normetanephrine levels were within the normal range. Serum adrenocorticotropic hormone (ACTH) levels were low (<1.0 pg/mL; normal range: 7.2-63.3 pg/ mL), and dehydroepiandrosterone sulfate levels were high (2,493 µg/dL; normal range: 92-399 µg/mL). There was a lack of circadian rhythm of cortisol, and overnight low-dose dexamethasone (1 mg) suppression tests revealed a lack of cortisol suppression (before, 18.4 ug/dL; after 19.4, ug/dL).
Examinations revealed that she had non-ACTH-dependent Cushing’s syndrome, not pheochromocytoma. Thereafter, we performed contrast-enhanced CT and positron emission to- mography (PET) studies, which revealed a left adrenal tu- mor [93×78×78.5 mm; maximum standardized uptake value (SUVmax), 9.5] with a solitary right lung metastasis (10×9.8 mm; SUVmax, 3.9) (Fig. 1).
After her condition recovered with intravenous infusion, she underwent adrenalectomy with open surgery on hospital day 8. A pathologic examination revealed that the adrenal
tumor was ACC according to the Weiss system. The tumor met 5 of the 9 criteria for ACC [mitotic rate >5/50 high- power fields, <25% clear cells, diffuse architecture (>1/3 of the tumor), necrosis, and sinusoidal invasion], and the Ki67/ MIB1 labeling index (Ki67/MIB1LI) of the tumor was 56% (Fig. 2).
While preparing for pulmonary resection, she suffered a second upper abdominal attack on hospital day 22. Labora- tory data showed that her serum amylase level and white blood cell count had increased (1,629 U/L and 11,260/mm3, respectively). CT showed acute pancreatitis and proximal main pancreatic duct (MPD) dilatation. Magnetic resonance cholangiopancreatography (MRCP) also revealed proximal MPD dilatation and diminishment of the distal MPD; how- ever, neither imaging modality revealed a distal pancreatic mass (Fig. 3). Therefore, we performed EUS to examine the pancreas on hospital day 27, which revealed a solitary pan- creatic mass (8 mm in diameter) that obstructed the proxi- mal pancreatic duct. Subsequently, we performed EUS-FNA with a 22-G needle (EZ shot 3 plus; Olympus, Tokyo, Ja- pan) (Fig. 4). Pathologic findings revealed a pancreatic mass that was a solitary pancreatic metastasis from ACC (Fig. 5). We diagnosed the patient with acute pancreatitis attacks manifesting as MIAP. To prevent recurrent acute pancreatitis caused by pancreatic metastasis, we performed endoscopic pancreatic stenting (EPS) via the minor papilla through the MPD on hospital day 35. Thereafter, she did not experience acute pancreatitis, but the pancreatic metastasis increased in
a
b
C
d
size. Synchronous multiple metastases from ACC required the initiation of mitotane-based chemotherapy (etoposide, doxorubicin, cisplatin, and mitotane) without resection of other organs. She underwent 12 cycles of mitotane-based chemotherapy, however, she ultimately died of the progres- sion of ACC at 26.5 months after the first admission.
Discussion
This case is the first report of MIAP from ACC that was diagnosed by EUS-FNA according to a search of the Pub- Med database using the key words “metastasis-induced acute
pancreatitis”, “adrenocortical carcinoma” and “endoscopic ultrasonography-guided fine-needle aspiration”. ACC is a rare and highly aggressive malignancy, with an annual inci- dence of 0.7-2.0 cases per million individuals. ACC can oc- cur at any age but has a peak incidence at 40-50 years, and women are more often affected than men, accounting for 55-60% of all cases (1).
Complete surgical resection is the only potentially cura- tive treatment for ACC (2). However, metastasis is common in patients with ACC, with approximately one-third of pa- tients having synchronous metastasis at the diagnosis (3). The most common metastatic sites are lung, liver, and bone.
A
B
A
B
After initial resection, locoregional recurrence becomes a challenge with pelvic, peritoneal, or retroperitoneal metasta- ses (4). In this case, liver metastasis was found three months after adrenalectomy, and she ultimately died of multiorgan disfunction from liver and lung metastases and peritoneal dissemination.
Pancreatic metastasis is rare compared with liver and lung metastasis. Adsay et al. reported secondary tumors of the pancreas in 81 (1.6%) of 4,955 adult autopsy cases and 38 (3.9%) of 973 surgical cases (5). The lung (34 cases), gas- trointestinal tract [stomach (10), colon (5), esophagus (4), rectum (1)], kidney (4), breast (3), and liver (2) were the most frequent sites of primary in the autopsy series, and most were non-Hodgkin’s lymphomas (11) in the surgical series (5).
According to a large single-center experience of diagnos- ing pancreatic metastases with EUS-FNA, the primary tumor sites were the kidney (21 cases), lung (8), skin (6), colon (4), breast (3), small bowel (2), stomach (2), liver (1), ovary (1), and bladder (1) in 49 patients. In addition, EUS-FNA confirmed pancreatic metastases in 47/49 patients (95.9%)
without complications (6). The adrenal gland was not men- tioned as a secondary tumor of the pancreas.
Baur et al. reported a case of pancreatic metastasis from ACC. Their case was one of recurrent ACC with a solitary pancreatic metastasis that occurred six years after resection of the primary tumor (7).
The current case was MIAP. Two weeks before the sec- ond attack of acute pancreatitis, PET-CT showed no proxi- mal pancreatic duct dilatation or pancreatic mass. We did not perform MRCP at the first attack of acute pancreatitis because we considered the etiology to have been alcohol, given the patient’s history of alcohol intake. We might have been able to detect narrowing of the MPD or slight up- stream dilatation had we performed MRCP after the first at- tack. At the second attack, CT and MRCP revealed proximal pancreatic duct dilatation but no solitary pancreatic mass. In contrast, EUS showed an obvious solitary pancreatic mass and EUS-FNA revealed pancreatic metastasis from ACC on pathological findings.
EUS is now regarded as the most sensitive imaging mo- dality for the detection of pancreatic lesions. According to a
systematic review, the overall sensitivities of EUS, CT, US, and MRI for the detection of pancreatic tumors were 94%, 74%, 67%, and 79%, respectively (8). For the detection of pancreatic tumor ≤20 mm, EUS had a higher sensitivity than contrast-enhanced CT (94.4% vs. 50.0%, n=36) (9). Further- more, EUS-FNA is the best modality for obtaining a tissue diagnosis; it has a sensitivity of 85-86.8% and specificity of 95.8-98% for determining the etiology of a solid pancreatic mass (10, 11).
There are no standard treatment approaches for MIAP due to the rarity of this disease and its poor prognosis. However, several authors reported that MIAP in patients with SCLC was treated successfully with chemotherapy to achieve pan- creatic metastasis shrinkage and loss without recurrent acute pancreatitis (12, 13). In the current case, ACC showed poor responsiveness to chemotherapy and radiotherapy; therefore, we inserted a pancreatic stent through the pancreatic metas- tasis from the minor papilla and decompressed the proximal pancreatic duct, similar to the EPS performed for MPD strictures in patients with chronic pancreatitis (14). On re- viewing the literature, Oku et al. reported that EPS was pre- viously performed for MIAP to prevent recurrent acute pan- creatitis (15).
In the current case, we were unable to determine whether alcohol or pancreatic metastasis caused the first attack of pancreatitis. However, her proximal MPD was dilated slightly on CT performed after the first attack, and had had no episodes of acute pancreatitis despite being a heavy drinker. Therefore, we suspect that pancreatic metastasis caused the acute pancreatitis.
In conclusion, we should consider the possibility of pan- creatic tumor when we encounter cases of acute pancreatitis with uncertain causes. EUS is a useful modality for detect- ing small pancreatic masses, and we emphasize the efficacy of EUS-FNA for the diagnosis of pancreatic metastasis.
The authors state that they have no Conflict of Interest (COI).
References
1. Fassnacht M, Kroiss M, Allolio B. Update in adrenocortical carci- noma. J Clin Endocrinol Metab 98: 4551-4564, 2013.
2. Allolio B, Hahner S, Weismann D, Fassnacht M. Management of adrenocortical carcinoma. Clin Endocrinol (Oxf) 60: 273-287,
2004.
3. Fassnacht M, Johanssen S, Quinkler M, et al. Limited prognostic value of the 2004 International Union Against Cancer staging clas- sification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer 115: 243-250, 2009.
4. Else T, Kim AC, Sabolch A, et al. Adrenocortical carcinoma. En- docr Rev 35: 282-326, 2014.
5. Adsay NV, Andea A, Basturk O, Kilinc N, Nassar H, Cheng JD. Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature. Virchows Archi 444: 527-535, 2004.
6. El H II, LeBlanc JK, Sherman S, et al. Endoscopic ultrasound- guided biopsy of pancreatic metastases: a large single-center expe- rience. Pancreas 42: 524-530, 2013.
7. Baur J, Schedelbeck U, Pulzer A, et al. A case report of a solitary pancreatic metastasis of an adrenocortical carcinoma. BMC Surg 15: 93, 2015.
8. Kitano M, Yoshida T, Itonaga M, Tamura T, Hatamaru K, Yamashita Y. Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer. J Gastroenterol 54: 19-32, 2019.
9. Sakamoto H, Kitano M, Suetomi Y, Maekawa K, Takeyama Y, Kudo M. Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas. Ultrasound Med Biol 34: 525-532, 2008.
10. Hewitt MJ, McPhail MJ, Possamai L, Dhar A, Vlavianos P, Monahan KJ. EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis. Gastrointest Endosc 75: 319-331, 2012.
11. Puli SR, Bechtold ML, Buxbaum JL, Eloubeidi MA. How good is endoscopic ultrasound-guided fine-needle aspiration in diagnosing the correct etiology for a solid pancreatic mass ?: a meta-analysis and systematic review. Pancreas 42: 20-26, 2013.
12. Tanaka H, Nakazawa T, Yoshida M, et al. Metastasis-induced acute pancreatitis in a patient with small cell carcinoma of the lungs. JOP 10: 557-561, 2009.
13. Okutur K, Bozkurt M, Korkmaz T, et al. Metastasis-induced acute pancreatitis successfully treated with chemotherapy and radiother- apy in a patient with small cell lung cancer. Case Rep Oncol Med 2015: 304279, 2015.
14. Dumonceau JM, Delhaye M, Tringali A, et al. Endoscopic treat- ment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 44: 784-800, 2012.
15. Oku T, Maeda M, Wada Y, et al. Successful management of metastasis-induced pancreatitis by endoscopic pancreatic duct stenting in a case of large cell lung cancer. Dig Endosc 19: 134- 138, 2007.
The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/ by-nc-nd/4.0/).
C 2019 The Japanese Society of Internal Medicine Intern Med 58: 2645-2649, 2019